Application Sponsors
NDA 018799 | BAXTER HLTHCARE CORP | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 300MG/ML | 0 | PRALIDOXIME CHLORIDE | PRALIDOXIME CHLORIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1982-12-13 | STANDARD |
CDER Filings
BAXTER HLTHCARE CORP
cder:Array
(
[0] => Array
(
[ApplNo] => 18799
[companyName] => BAXTER HLTHCARE CORP
[docInserts] => ["",""]
[products] => [{"drugName":"PRALIDOXIME CHLORIDE","activeIngredients":"PRALIDOXIME CHLORIDE","strength":"300MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"PRALIDOXIME CHLORIDE","submission":"PRALIDOXIME CHLORIDE","actionType":"300MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)